The latest new contracts, like scPharmaceuticals’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors
scPharmaceuticals Inc. announced a partnership with Perceptive Advisors for non-dilutive financings totaling up to $125 million. This will be used to repay existing debt and fund activities related to the ongoing commercialization of FUROSCIX.
Company Information
Company
scPharmaceuticals
Location
Massachusetts, United States
About
scPharmaceuticals Inc. (Nasdaq: SCPH) is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs.
Predictive Intelligence
Strategic
ML-powered predictions for scPharmaceuticals's next move